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ABSTRACT
Risks of heavy metals-induced severe bone disorders generate interest to their toxicity. The present study was undertaken to monitor 
the biochemical and antioxidant status of bone of 30 and 80 days old male Wistar rats exposed to 5 week lead treatment. At the end 
of study, the rats were sacrificed, their long bone i.e. femur were excised, cleaned of soft tissue, minced and homogenized. Nucleic 
acid content, alkaline phosphatase, lipid peroxidation, catalase, glutathione S-transferase and superoxide dismutase were determined 
in bone. In both groups of treated animals lead treatment increased the production of malondialdehyde, while reducing activities of 
catalase, glutathione S-transferase and superoxide dismutase, indicating that it causes oxidative stress. Parallely with these effects lead 
significantly reduced the nucleic acid content and the activity of alkaline phosphatase, considered as biomarkers of osteoblast’s func-
tion, conditions and development of bones. Moreover the concentrations of copper, zinc, iron and sodium were reduced in the excised 
bones. The present study indicates that the lead induced bone toxicity and its deteriorated development is the consequence of a 
primary oxidative stress. Our results may be helpful in understanding the modulation of biochemical parameters under lead toxicity. 
KEY WORDS: bone; lead toxicity; DNA; RNA; ALP; antioxidant enzymes and trace element analysis 
Correspondence address: 
Prof. Durg Vijay Rai, PhD.
Department of Biophysics, Panjab University, 
Chandigarh, 160014, India
PHONE: 9417527260
E-MAIL: dvrai@pu.ac.in 
nervous system. Millions of children have enough lead in 
their blood to reduce intelligence and attention span, cause 
learning disabilities, and damage permanently a child’s 
brain and nervous system (ATSDR 2005, 2007).
Metal-induced toxicity, with an emphasis on the gen-
eration and role of reactive oxygen species (ROS) in case of 
bone is not well known. Metal-mediated formation of free 
radicals causes various modifications to deoxyribonucleic 
acid (DNA) bases, enhances lipid peroxidation, and alters 
calcium and sulfhydryl homeostasis. Lipid peroxides, 
formed by the attack of radicals on polyunsaturated fatty 
acid residues of phospholipids, can further react with redox 
metals finally producing mutagenic and carcinogenic malo-
ndialdehyde (MDA), 4-hydroxynonenal and other exocyclic 
DNA adducts (etheno and/or propano adducts).
The primary route for heavy metal toxicity is depletion 
of glutathione and bonding to sulfhydryl groups of proteins. 
Lead toxicity damages cellular material and alters cellular 
genetics (Lyn, 2006). The pathogenesis of lead toxicity is 
multifactorial, as lead causes oxidative stress by inducing 
the generation of ROS, reducing the antioxidant defense sys-
tem of cells via depleting glutathione, interfering with some 
essential metals, inhibiting sulfhydryl dependant enzymes 
Introduction
Lead is one of the first discovered and widely known metals 
commonly encountered in the environment (Shoty et al,, 
1998). Lead poisoning is one of the foremost environmental 
health threats (Juberg et al., 1997). Humans lead poison-
ing develops if the people are exposed to harmful levels 
of lead-contaminated dust from its continued release into 
the environment as an exhaust emission product of leaded 
gasoline, as well as due to its wide spread industrial use 
(deteriorated lead-based paints and lead-contaminated 
soil). Immediately after absorption, lead enters into the 
blood, which is then distributed particularly to the liver and 
kidneys, and is then stored in the bones and cause damage 
of liver, kidneys, heart, male gonads and affects immune and 
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or antioxidant enzymes activities and/or increasing sus-
ceptibility of cells to oxidative attack by altering membrane 
integrity and fatty acid composition (Inouye et al., 2001; 
Hande and Naran, 2000). Antioxidants are the compounds 
that protect cells against ROS or free radicals in the body. 
Under physiological conditions, ROS are cleared from the 
cells by the action of superoxide dismutase (SOD), catalase 
(CAT), or glutathione peroxidase (GPX). When free radicals 
or oxidants are produced in abundance, cells suffer from oxi-
dative stress. Fortunately, the balance between free radical 
generation in tissues and endogenous antioxidants activity 
prevents oxidative stress in physiological conditions. Thus 
cellular health depends on maintenance of this balance. The 
free-radicals are named troublemakers and originate mostly 
from ROS in the mammalian tissues. Free-radicals acquire 
an electron from the molecule next to it, then that molecule 
or atom may become a free-radical. It becomes unstable and 
will try to take another electron from any other molecule in 
its immediate environment, and so on. Thus, there is a chain 
reaction of molecules that are desperately seeking comple-
tion, leaving severe damage in their surroundings wherever 
an electron pair is broken. If free radicals capture electrons 
from lipids of cell membranes, the evoked lipid peroxidation 
damages the membrane functions.
CAT, SOD, Glutathione S-transferases (GST) and 
GPX are the main endogenous antioxidant enzymes. CAT 
commonly found in living tissue consists of four subunits, 
containing heme group with iron in the active center. This 
enzyme converts toxic peroxides to harmless products of 
water and oxygen (Luck, 1971). The production of hydrogen 
peroxide (H2O2) in eukaryotic cells is an end product of the 
reaction between various oxidases and SOD. Accumulation 
of H2O2 may damage the cells due to oxidation of proteins, 
DNA, and lipids, thus causing cell death and mutagenesis 
(Tada-Oikawa et al., 1999; Kowaltowski et al., 2000). Recent 
studies brought evidence that oxidative stress modulates 
osteoblastic differentiation of bone cells (Mody et al., 2001). 
SOD is a protein with copper and zinc, or manganese as 
cofactors and catalyzes dismutation of superoxide (O2
•ˉ) 
into oxygen and H2O2 (Frodovich, 1995). GSTs catalyse the 
conjugation of reduced glutathione via the sulfhydryl group, 
to electrophilic centers on wide variety of substrates. This 
activity is useful in detoxification of products of oxidative 
stress, such as peroxidised lipids (Hayes and Pulford, 1995). 
GPX is an enzyme with peroxidase activity whose main 
biological role is to protect the organism from oxidative 
damage. The biochemical function of GPX is to reduce 
lipid hydroperoxides to their corresponding alcohols and to 
reduce free H2O2 to water (Muller et al., 2007). 
Most research about lead exposure on various antioxi-
dant enzymes and tissues has been mainly experimental and 
the results are often divergent. The purpose of our study was 
therefore to evaluate the activity of endogenous antioxidant 
enzymes and the production of ROS in bone with refer-
ence to other bone marker. Biochemical changes including 
nucleic acid content, alkaline phosphatase (ALP) activity, 
antioxidant defense system enzymes and malodialdehydes 
(MDA) level of femur under lead administration were 
monitored. The study paves the path in understanding the 
cellular basis of lead induced alterations leading to changes 
in bone metabolism.
Methods
Experimental modality
To carry out the present investigation, male Wistar rats 
were procured from the Central Animal House of Panjab 
University, Chandigarh. The animals were housed in 
polypropylene cages bedded with sterilized rice husk. They 
were given free access to clean drinking water (tap water) 
and standard animal pellet diet (Ashirwad Industries, 
Kharar, Punjab, India), throughout the experiment. The 
temperature of the animal room was maintained at 21±1ºC, 
humidity 50–60% and dark and light cycle was 12 hrs. The 
animals were acclimatized for one week to laboratory con-
ditions before the experiment. The experimental protocols 
were approved by the Institutional Ethics Committee and 
conducted according to Indian National Science Academy 
Guidelines for the use and care of experimental animals.
Chemicals used
Lead acetate (~99% pure) was purchased from Qualigens 
Fine Chemicals: A division of Glaxo Smith Kline 
Pharmaceuticals Limited, Mumbai, India. Ethylene diamine 
tetraacetic acid (EDTA), Diaphenylamine (DPA) and Orcinol 
from S.D fine chemicals Ltd. Paranitro phenyl phosphate 
(PNPP), Hydrogen peroxide, Thio barbituric acid (TBA), 
Trichloroacetic acid and glacial acetic acid from E. Merk 
(India) Pvt. Ltd, Sisco research lab Pvt Ltd.
Experimental design
Forty male Wistar rats were taken in two age groups i.e. 
30 day’s old (controls /CI/ and experimental /Lead I/) and 
80 day’s old (controls /CII/ and experimental /Lead II/) 
animals. To produce a subclinical toxicity, lead (as lead 
acetate 250 mg/ml) was provided ad libitum in drinking 
water for five weeks. Glacial acetic acid was added to the 
drinking water of lead administered groups at a concentra-
tion of 12.5 μl/l to prevent the precipitation of lead acetate. 
Blood was collected by puncturing the ocular vein before 
scarification, kept at room temperature for 2–3 hrs and then 
centrifuged at 1290 × g for 15 min to obtain serum. The 
obtained serum was used for analysis of ALP. At the end of 
the study, rats from all four groups were sacrificed by decapi-
tation and their long bone i.e. femurs were excised, cleaned 
of soft tissue. The femurs were cut into the metaphyseal and 
diaphyseal part (Figure 1) with the help of bone cutter and 
then these parts were minced and homogenized 10% of their 
total weight in sodium phosphate buffer (0.1 M, pH 7.5) in 
pestle mortar and were centrifuged at 10,000 g for 30 min. 
The supernatant was collected and used for biochemical 
assays (SOD, CAT, GST and LPO). 
Estimation of nucleic acids
To measure nucleic acid content of respective bone powders, 
they were defatted with chloroform / methanol (1: 1 in 20
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volume) overnight. Then the residue was demineralized in 
0.5 M EDTA/ 50 mM Tris-HCl, pH 7.4 containing 1M NaCl. 
Demineralization was continued for two weeks and then the 
nucleic acid contents were estimated. The demineralized 
bone powder was dissolved in 0.1 ml of 0.1 N NaOH. 20μl of 
sample was diluted to 100 μl by addition of 80 μl of distilled 
water and used for estimation of DNA and RNA. The DNA 
and RNA were determined by the method of Plummer 
(Plummer, 1988). In case of DNA, to 2 ml of above sample 
(extract) 4 ml of diphenylamine (DPA) reagent was added 
and the samples were kept in boiling water bath at 90 °C for 
10 min. After cooling, the samples were read at 595 nm and 
DNA content was estimated using the linear standard curve 
of standard resolution of DNA.
In case of RNA, to 2 ml of sample (extract), 3 ml of 
Orcinol reagent was added and the samples were kept in 
boiling water bath at 90 °C for 15 min. After completion of 
incubation period the samples were cooled and the color 
formed was read at 660 nm.
Assessment of ALP
For ALP estimation, bone tissue was minced and homog-
enized in 3 ml of an ice-cold 6.5 mM barbital buffer (pH 7.4) 
and ultracentrifuged for 60 s. Further, it was centrifuged for 
5 min at 3000 rpm, and its supernatant fraction was used to 
measure ALP activity. The activity of ALP was estimated 
according to the method of Bergmeyer et al. (1980). To 
900 μl PNPP (Para nitro phenyl phosphate), 100 μl distilled 
water and 1.3 ml glycine buffer were added and incubated 
for 5 min at 37 ºC. Then 200 μl of enzyme extract was added 
and tubes were further incubated for 30–45 min at 37 ºC. To 
stop the reaction 3.5 ml of 0.1 N NaOH was added and liber-
ated PNP (Para nitro phenol) was measured by spectropho-
tometer at 420 nm. The enzymatic activity was expressed 
as enzyme protein content (mg) using PNP content (nmol) 
produced by reaction through incubation for one minute.
Assessment of CAT
CAT was estimated directly as described by Luck (1971).
Assessment of SOD
The activity of SOD was estimated according to the method 
of Kono (1978).
Assessment of GST 
GST activity was determined spectrophotometrically 
according to the method of Habig et al. (1973). 
MDA assay
LPO in femur was performed according to the method of 
Devasagayam et al. (1987). The reaction mixture consisted 
of 0.1 ml 0.15 mol/l Tris-HCl buffer (pH  7.4), 0.3 ml of 
10 mmol/l KH2PO4 and 0.2 ml of tissue extract in a total 
volume of 2 ml. The reaction mixture was incubated at 
37 ºC for 20 min with constant shaking. The reaction was 
stopped by the addition of 1 ml of 10% TCA. The tubes were 
shaken well and 1.5 ml TBA was added and heated in a boil-
ing water bath for 20 min. The pink colored complex was 
formed whose absorbance was read at 532 nm. The amount 
of MDA formed (index of lipid peroxidation) was calculated 
using an extinction coefficient of 1.56 × 105 M–1cm–1 for 
MDA-TBA chromophore and the results are expressed as 
nmoles of MDA formed /min/mg of protein.
Protein estimation
Protein was estimated by the method of Lowry et al. (1951).
Elemental analysis (Atomic Absorption Spectroscopy)
Trace elemental analysis for bone samples was done 
using the Perkin Elmer, Intensitron Atomic Absorption 
Spectrometer (Model 3100). For atomic absorption, bones 
were digested in 0.5 M EDTA (demineralizing solution). 
The bones were allowed to demineralize for 96 hrs at room 
temperature. After demineralization the bones were dried 
and weight loss was found. The bones were considered to be 
fully demineralized if the weight loss was –70% of the dry 
weight. The demineralizing solution was used as a sample 
for elemental analysis. 
Statistical Analysis
Statistics analysis of the data was performed by analysis of 
variances (one way ANOVA). Following one way ANOVA 
post Hoc test using least significance difference (LSD) and 
by student ‘t’ test at p=0.05 using SPSS statistical software 
data for individual parameters represents average value 
calculated from three parallels.
Results
Significant decrease (p<0.001) in DNA and RNA content 
of femoral diaphyseal and metaphyseal tissue was observed 
in experimental groups as compared to their respective 
controls (Table 1). About 35.02% and 43.9% reduction was 
found in the metaphyseal DNA, whereas 48.3% and 49.1% 
reduction was found in the diaphysial DNA of both age 
Metaphyseal
Diaphyseal
Figure1. Division of femur to metaphyseal and diaphyseal part.21
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groups, respectively. Similarly reduction of 35.86% and 53% 
was found in the metaphyseal RNA in both age groups.
ALP activity significantly (p<0.001) decreased in both 
the diaphyseal and metaphyseal femoral tissue of treated 
groups, as compared to their respective controls. Similar 
trend was seen in ALP activity of serum in which there was 
a reduction in the activity to about 57.3% and 61.1% in the 
two age groups, respectively (Table 2).
Lead treatment increased the level of MDA almost to the 
same extent, as compared to their respective control values 
Table 1. Nucleic acid content (DNA/ RNA).
Groups
DNA (μgm /mg wet tissue) RNA (μgm /mg wet tissue)
Metaphyseal 
tissue
Diaphyseal 
tissue
Metaphyseal 
tissue
Diaphyseal 
tissue
CI 3.34±0.13 1.78±0.04 2.37±0.23 1.50±0.05
Lead I 2.17±0.10*** 0.92±0.01*** 1.52±0.07*** 0.80±0.05***
CII 3.57±0.22 1.85±0.06 3.00±0.12 1.67±0.07
Lead II 2.00±0.05*** 0.94±0.03** 1.41±0.25*** 0.82±0.05***
Data: Mean ± Standard Deviation (N=10). Statistically significant differ-
ences are represented by: *p≤0.05, **p≤0.01, ***p≤0.001 lead treated 
group w.r.t. control
Table 2. Alkaline Phosphatase (ALP) activity in bone and serum.
Groups
ALP Activity 
(μmoles/ min/ mg protein) in bone
Serum ALP Activity
(10-3μmoles/min/
mg protein)
Metaphyseal tissue Diaphyseal tissue
CI 2.81±0.28 1.68±0.07 5.34±0.25
Lead I 1.33±0.07*** 0.99±0.05*** 2.28±0.04***
CII 3.33±0.14## 1.74±0.07 5.64±0.28#
Lead II 1.28±0.01*** 0.94±0.10** 2.19±0.12***
Data: Mean ± Standard Deviation (N=10). Statistically significant differ-
ences are represented by: *p≤0.05, **p≤0.01, ***p≤0.001 lead treated 
group w.r.t. control, #p≤0.05, ##p≤0.01, ###p≤0.001 CII w.r.t CI
Table 3. CAT, SOD, GST activity and LPO in bone.
Groups
LPO (nmoles MDA)
formed/mg protein
Catalase (μmoles H2O2)
formed/min/mg protein
SOD
(Units/mg protein)
GST (nmoles of conjugate) 
formed/min/mg protein
CI 2.74±0.06 19.83±0.74 12.50±1.63 2.12±0.13
Lead I 5.74±0.008*** 10.61±0.91*** 8.99±0.71** 1.22±0.16***
CII 2.75±0.06 21.66±1.32## 14.25±0.92# 2.22±0.08#
Lead II 5.84±0.07*** 12.42±1.27*** 7.12±0.63*** 1.10±0.04***
Data: Mean ± Standard Deviation (N=10). Statistically significant differences are represented by: *p≤0.05, **p≤0.01, ***p≤0.001 lead treated group w.r.t. 
control, #p≤0.05, ##p≤0.01, ###p≤0.001 CII w.r.t CI
Table 4. Trace elemental analysis
Groups
Concentration (ppm)
Copper (Cu) Zinc (Zn) Iron (Fe) Sodium (Na)
CI 1.27 ± 0.15 1.74±0.04 6.34±0.21 1.66±0.09
Lead I 0.78±0.01*** 1.21±0.07*** 5.40±0.16*** 1.22±0.05***
CII 1.32± 0.31 1.82±0.03 6.62±0.17 1.81±0.12
Lead II 0.76±0.02** 1.27±0.03*** 5.19±0.11*** 1.08±0.07***
Data: Mean ± Standard Deviation (N=10). Statistically significant differ-
ences are represented by:  *p≤0.05, **p≤0.01, ***p≤0.001 lead treated 
group w.r.t. control
in the young (by 47.7%) and old animals (47.1%) (Table 3). Lead 
treatment reduced the activity of the antioxidant enzymes 
CAT, SOD and GST in femur of lead treated groups both 
in young and old animals when compared to their respec-
tive controls (Table 3). Trace elemental analysis by atomic 
absorption spectroscopy revealed reduction in the concen-
tration of Cu, Zn, Fe and Na ions when compared with their 
respective controls (Table 4). We have found reduction in the 
concentration of Cu to about 38.5%, Zn to about 30.45%, Fe 
to about 14.82% and Na to about 26.50% for both age groups. 
Discussion
In the present study, decrease in ALP activity and nucleic 
a ci d  co n te n t  was  o bse rv ed  in  bo th  dia p h yseal  ( co rti cal  
bone) and metaphyseal (trabecular bone) femoral tissue 
which infer that lead toxicity has effect on both cortical 
and trabacular bones. Effect of lead toxicity on bone cell 
function has been reported earlier (Pounds et al., 1991). 
DNA content in bone tissues is an index of the number of 
bone cells (Canalis et al., 1989). Bone ALP is the enzyme 
marker of osteoblast activity, and hence participates in the 
bone mineralization process (Majeska and Wurthier, 1975). 
Earlier reports have shown the inhibitory effect of lead on 
osteoblastic expression (Klein and Wiren, 1993). Through 22
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its action to inhibit nucleic acid content and osteoblastic 
activity, lead may limit attainment of peak bone mass and 
disrupt the tight coupling of bone formation and resorp-
tion necessary for normal bone modeling. Various reports 
suggested correlation between mRNA levels for bone cell 
proteins and bone formation in long bones of maturing rats 
(Turner and Spelsberg, 1991). ALP activity also decreases 
in serum. Earlier experiments have also shown that lead 
induced inhibition of specific steady state mRNA levels is 
responsible for reduction in ALP activity (Klein and Wiren, 
1993). Our results clearly demonstrated that lead impairs 
the nucleic acids metabolism and ALP activity. Lead has 
more effect on developing skeleton or children as compared 
to adults because children have increased absorption rates 
and retention levels and lead burden (Shih Hu et al., 2007; 
Smith et al., 2008).
To fully understand the significance of bone as a target 
tissue of lead toxicity, as well as a reservoir of systemic lead, 
it is necessary to define the effects of lead on the cellular 
and enzymatic components of bone. So, in the present study, 
various antioxidant enzymes were estimated to scrutinize 
the effect of lead on antioxidant defense system of body. 
Lead induced oxidative stress, increased the levels of MDA 
in the process of LPO. MDA has got high reactivity towards 
amino groups; it inhibits the synthesis of nucleic acids and 
proteins and also deactivates the enzymes (Bird and Draper, 
1980). Thus the decrease in femur antioxidant enzymes 
activities and nucleic acid levels observed after lead treat-
ment may be due to heightened LPO. Lead treatment signifi-
cantly decreased the activity of SOD, CAT and GST when 
compared to control groups. The decrease in SOD activity 
may result in accumulation of O2
•ˉ, which has been shown 
to inhibit other antioxidant enzymes (Kono and Fridovich, 
1982). SOD is responsible for O2
•ˉ dismutation to H2O2, a 
species that is longer active than O2
•ˉ. Lead toxicity leads 
to free radical damage via generation of ROS or by direct 
depletion of antioxidant reserves (Ercal et al., 2001). A sig-
nificant decrease in CAT suggests an increased utilization 
of CAT in response to ROS in the process converting H2O2 
to water. There is strong relationship between oxidative 
stress and bone loss (Sánchez-Rodríguez et al., 2007; Liu et 
al., 2008; Shen et al., 2008). Trace elements are required for 
proper functioning of various enzymes. SOD, an antioxi-
dant defense enzyme requires copper and zinc as cofactors. 
Copper is required by lysyl oxidase that catalyses cross 
linking of lysine and hydroxyproline in collagen, contribut-
ing to the mechanical strength of collagen fibrils. ALP and 
collagenase also utilize zinc as cofactor. Since copper and 
zinc play an important role in bone metabolism and turn 
over decrease in their concentration as shown in the pres-
ent study interfere with bone development and functioning. 
Significant decrease in the amount of trace elements in lead 
treated groups reflects the disruption in collagen synthesis, 
bone turnover and metabolism. The decrease in the trace 
e l e m e n t  c o n c e n tr a ti o n  can  als o  b e  c o rr e l a t e d  wi th  th e  
decrease in various enzymes activities as these elements are 
recognized as the cofactors of various enzymes.
Based on our results we may assume, that increased 
oxidative stress in lead treated bone results from the 
accelerated formation of oxidants and reduced antioxidant 
defense capacity of the bone cells or by both. These results 
may pave a new pathway in understanding of mechanism of 
lead toxicity on bone.
Acknowledgment
We would like to acknowledge RSIC/CIL Dept. of Panjab 
University, Chandigarh for their support for giving 
instrumentation facility. Financial assistance provided 
by University Grant Commission (UGC) under the major 
research project is also gratefully acknowledged.
REFERENCES
Agency for Toxic Substances and Disease Registry. (ATSDR, 2005). Draft toxico-
logical proﬁ  le for lead, pp.102–225, US Department of health and human ser-
vices, Atlanta, Georgia, USA.
Agency for Toxic Substances and Disease Registry. (ATSDR, 2007). Case stud-
ies in Environmental Medicine Lead Toxicity, Course: WB 1105, August 20, At-
lanta, Georgia, USA.
Bergmeyer H and Bernt E. (1950). Practical Clinical Biochemistry (Varley H, 
Gowenlock AH, Bell M eds), 5th Edn, pp 741–812 William Heinmann Medical 
Books Ltd London.
Bird RP and Draper HH. (1980). Eﬀ  ect of malonaldehyde and acetaldehyde on 
cultured mammalian cells: Growth, morphology, and synthesis of macromol-
ecules. J Toxicol Environ Health 6(4): 811–823.
Canalis E, Centrella M, Bunch W and McCarthy TL. (1989). Insulin like growth 
factor I mediates selective anabolic eﬀ  ects of PTH in bone cultures. J Clin In-
vest 83: 60–65.
Devasagayam TD and Terachand U. (1987). Decreased lipid peroxidation in rat 
kidneys during gestation. J Biochem Biophys Res Commun 145: 134–138.
Ercal N, Gurer-Orhan H and Aykin-Burns N. (2001). Toxic metals and oxidative 
stress part I: mechanisms involved in metal-induced oxidative damage. Re-
view. Curr Top Med Chem 1(6): 529–539.
Frodovich I. (1995). Superoxide radical and superoxide dismutase. Annu Rev 
Biochem 64: 97–112.
Habig WH, Pabst MJ and Jackoby WB. (1973). The ﬁ  rst enzymatic step in mer-
capturic formation. J Biol Chem 249: 7130–13 9.
Hande, G and Naran, E. (2000). Can antioxidants be beneﬁ  cial in the treatment 
of lead poisoning? Free Radic. Biol.Med 29(10), 927–945.
Hayes JD and Pulford DJ. (1995). The glutathione S-transferase supergene fam-
ily: regulation of GST and the contribution of the isoenzymes to cancer che-
moprotection and drug resistance. Crit Rev Biochem Mol Biol 30: 445–600.
Inouye, Yoshio et al. (2001). Comparative Study on in vitro Inhibitory Eﬀ  ects of 
Heavy Metals on Rabbit Drug-Metabolizing Enzymes. Journal of Health Sci-
ences 47: 14–20.
Juberg, DR, Kleiman C F, Kwon, SC. (1997). Position paper of the American coun-
cil on science and health: Lead and human health. Ecotoxicol. Environ. Saf 38, 
162–180. 
Klein RF and Wiren KM. (1993). Regulation of osteoblastic gene expression by 
lead. Endocrinology 132(6): 2531–2537.
Kono Y and Fridovich I. (1982). Superoxide radical inhibits catalase. J Biol Chem 
257(10): 5751–5754.
Kono Y. (1978). Generation of superoxide radical during autooxidation of hy-
droxylamine and an assay for superoxide dismutase. Arch. Biochem. Biophys 
186: 189–195.
Kowaltowski AJ, Vercesi AE, Rhee SG and Netto LE. (2000). Catalases and thio-
redoxin peroxidase protect Saxxharomyces cerevisiae against Ca2+ induced 
mitochondrial memebrane permeabilization and cell death. FEBS Lett 473: 
177–182.
Liu G, Men P, Kenner GH and Miller SC. (2008). Therapeutic eﬀ  ects of an oral 
chelator targeting skeletal tissue damage in experimental postmenopausal 
osteoporosis in rats. Hemoglobin 32(1–2): 181–190.23
Also available online on setox.eu/intertox & versita.com/science/medicine/it
Interdisciplinary Toxicology. 2009; Vol. 2(1): 18–23
Copyright © 2009  Slovak Toxicology Society SETOX
Lowry OH, Rosebrough NJ, Farr AL and Randall RJ. (1951). Protein measurement 
with folin phenol reagent. J Biol Chem 193: 265–275.
Luck H. (1971). In: Methods of enzymatic analysis. Ed: H.U. Bergmeyer, Academic 
Press, New York 885–893. 
Lyn P. (2006). Lead toxicity, a review of the literature. Part I: exposure, evaluation 
and treatment. Altern Med Rev 11: 2–22.
Majeska RJ and Wurthier RE. (1975). Studies in matrix vesicles in epiphyseal car-
tilage I. In vivo incorporation of 32P orthophosphate into phospholipids of 
chondrocyte, membrane and matrix vesicle fraction. Biochem Biophys Acta 
391: 51–60.
Mody Nilam, Parhami Farhad, A. Saraﬁ  an Theodore and Linda L. Demer. (2001). 
Oxidative stress modulates osteoblastic diﬀ  erentiation of vascular and bone 
cells. Free radiacl biology and medicine 31(4): 509–519.
Muller FL, Lustgarten MS, Jang Y, Richardson A, and Van Remmen H. (2007). 
Trends in oxidative aging theories. Free Radic. Biol.Med 43, 477–503.
Plummer DT. (1988). In: Introduction to practical biochemistry. Third Edition, 
Copyright © Tata Mac Graw Hill Company (UK) Limited 220–221.
Pocock NA, Eisman JA, Hopper JL, Yeates MG, Sambrook MG and Ebert TS. 
(1987). Genetic determinants of bone mass in adults: A twin study. Journal of 
Clinical investigation 80: 706–710.
Pounds JG, Long GJ, and Rosen JF. (1991). Cellular and molecular toxicity of lead 
in bone. Environ Health Perspect 19: 17–32.
Sánchez-Rodríguez MA, Ruiz-Ramos M, Correa-Muñoz E and Mendoza-Núñez 
VM. (2007). Oxidative stress as a risk factor for osteoporosis in elderly Mexi-
cans as characterized by antioxidant enzymes. BMC Musculoskelet Disord 8: 
124.
Shen CL, Wang P, Guerrieri J, Yeh JK and Wang JS. (2008). Protective eﬀ  ect of 
green tea polyphenols on bone loss in middle-aged female rats. Osteoporos 
Int 19(7): 979–990.
Shih RA, Hu H, Weisskopf MG and Schwartz BS. (2007). Cumulative lead dose 
and cognitive function in adults: a review of studies that measured both 
blood lead and bone lead. Review. Environ Health Perspect 115(3): 483–492.
Shoty K, Weiss DW, Appleby PG, Chebrkin AK, Gloor RFM, Kramens JD et al. 
(1998). History of atmosphearic lead deposition since 12,370. (14) C yr BP from 
a peat bog, jura mountains, Switzerland Science 281, 1635 – 1640.
Smith DM Jr, Mielke HW and Heneghan JB. (2008). Subchronic Lead Feeding 
Study in Male Rats.Arch Environ Contam Toxicol [Epub ahead of print].
Tada-Oikawa S, Oikawa S, Kawanishi M, Yamada M and Kawanishi S. (1999). 
Generation of hydrogen peroxide precedes loss of mitochondrial meme-
brane potential during DNA alkylationinduced apoptosis. FEBS Lett 442: 65–
69.
Turner RT and Spelsberg TC. (1991). Correlation between mRNA levels for bone 
cell proteins and bone formation in long bones of maturing rats. Am J Physiol 
1(3 Pt 1): E348–53.